Employees – University of Copenhagen

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group

Research output: Contribution to journalJournal article

Charlotte Levin Tykjær Jørgensen, Christina Annette Bjerre, Bent Laursen Ejlertsen, Karsten D. Bjerre, Eva Balslev, Annette Bartels, Nils Brünner, Dorte L. Nielsen

Original languageEnglish
Article number360
JournalB M C Cancer
Number of pages14
StatePublished - 2014

    Research areas

  • TIMP-1, Gemcitabine, Docetaxel, Breast cancer, Prediction, Prognosis

Number of downloads are based on statistics from Google Scholar and www.ku.dk

No data available

ID: 125791294